8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2016 / Intervention study (mice and humans)
Investigators studied the effects of dietary protein dilution (DPD) on metabolic health markers in mice and humans, as well as its mechanistic pathways in murine models. DPD increased serum markers of metabolic health in both mice and humans. In lean mice, DPD promoted metabolic inefficiency by increasing carbohydrate and fat oxidation, and in murine models of obesity, it prevented and curtailed impaired glucose homeostasis independently of obesity and food intake. The metabolic improvements required liver-derived FGF21, induced by liver-integrated stress response-driven NUPR1 triggered by insufficiency of select nonessential amino acids.
Maida A, Zota A, Sjøberg KA, et al. J Clin Invest, 2016. PMID 27548521
2016 / Randomized controlled trial
A randomized pilot trial assigned 26 adults with obesity to 8 weeks of zero-calorie alternate-day fasting or daily calorie restriction (-400 kcal/day). Weight loss did not differ significantly between groups at 8 weeks (-8.2 ± 0.9 kg for fasting vs -7.1 ± 1.0 kg for restriction), nor were there differences in lipids, body composition, or insulin sensitivity. After 24 weeks of unsupervised follow-up, weight regain was similar between groups.
Catenacci VA, Pan Z, Ostendorf D, et al. Obesity (Silver Spring), 2016. PMID 27569118
2016 / Randomized controlled trial
In a 12-week trial of 80 overweight and obese women in a weight-loss program, 69 completed allocating their main energy intake to lunch or dinner. The lunch group achieved greater reductions in weight (-5.85 kg vs. -4.35 kg; P = 0.003), body mass index (P = 0.003), fasting insulin (P < 0.001), and insulin resistance (P = 0.001) than the dinner group. Fasting glucose and lipid profiles did not differ between groups.
Madjd A, Taylor MA, Delavari A, et al. Am J Clin Nutr, 2016. PMID 27581472
2016 / Clinical trial
A clinical trial examined postmenopausal women with obesity undergoing approximately 10% weight loss on hypocaloric diets containing either 0.8 g or 1.2 g protein/kg/day. The higher-protein diet reduced lean tissue loss by roughly 45%. However, higher protein intake also eliminated the weight-loss-induced gains in muscle insulin signaling and insulin-stimulated glucose uptake, while preventing cellular adaptations in oxidative stress pathways.
Smith GI, Yoshino J, Kelly SC, et al. Cell Rep, 2016. PMID 27732859
2016 / Comparative clinical trial
Systemic inflammation was assessed three months after gastric bypass (n=15) or a very low-calorie diet (n=12) in morbidly obese women with type 2 diabetes, plus 12 lean controls. Both interventions lowered CRP and leptin while raising adiponectin. However, the diet was linked to reductions in TNF-alpha, IL-2, and IL-6, whereas bypass was linked to increased TNF-alpha and higher numbers of activated cytotoxic T and B cells.
Lips MA, van Klinken JB, Pijl H, et al. Metabolism, 2016. PMID 27733249
2016 / Randomized crossover trial series
Researchers evaluated high-calorie diets enriched with saturated fatty acids (SFA) or carbohydrates (CARB) compared to a standard eucaloric AHA control diet in subjects with NGT or IGT. Steady state plasma glucose (SSPG) increased by 83±74% versus control after a 24-hour SFA diet across the entire cohort (n=38; NGT: 92±82%, n=22; IGT: 65±55%, n=16; all p<0.001) and by 55±32% after a single SFA breakfast (p=0.008, n=7). The SSPG elevation was 24±31% after an overnight fast (p=0.04, n=10) and further attenuated 24 hours after returning to the control diet (19±35%, p=0.09, n=11), while a 24-hour CARB diet did not significantly increase SSPG (26±50%, p=0.11, n=12).
Koska J, Ozias MK, Deer J, et al. Metabolism, 2016. PMID 27733250
2016 / Randomised crossover study
A randomised crossover study evaluated 41 adults with type 2 diabetes mellitus comparing advice to walk 30 minutes each day versus advice to walk 10 minutes after each main meal for 2-week periods. Postprandial glycaemia iAUC over 3 hours post-meal was significantly lower when walking after meals compared with a single daily walk (ratio of geometric means 0.88, 95% CI 0.78, 0.99). The improvement was especially marked after the evening meal (0.78, 95% CI 0.67, 0.91), when carbohydrate consumption was highest. One participant died during the 30-day washout period, an event not judged to be related to study participation.
Reynolds AN, Mann JI, Williams S, et al. Diabetologia, 2016. PMID 27747394
2016 / Open, parallel, randomized study
A 12-week open parallel randomized study compared a vegetarian diet to a conventional diet, both with the same caloric restriction (-500 kcal/day), alongside supervised aerobic exercise in 74 patients with type 2 diabetes. All meals were provided for the entire study duration. VO2max increased by 12% in the vegetarian group (p < 0.001) with no significant change in the conventional group (p = 0.667; group x time p = 0.004). Maximal performance (Watt max) increased by 21% in the vegetarian group (p < 0.001) but did not change in the conventional group (p = 0.334; group x time p = 0.048).
Veleba J, Matoulek M, Hill M, et al. Nutrients, 2016. PMID 27792174
2016 / Randomized, double-blind, placebo-controlled, crossover trial
In a randomized, double-blind, placebo-controlled crossover trial, 42 Japanese subjects consumed placebo or kale-containing food (7 g active-L or 14 g active-H) with a high-carbohydrate meal. Maximum plasma glucose concentrations (Cmax) were significantly lower for active-L (163±24 mg/dl) and active-H (162±23 mg/dl) compared with placebo (176±26 mg/dl; P<0.01). Glucose AUC0-2 h was also significantly lower for active-L (268±43 mg/h/dl) and active-H (266±42 mg/h/dl) versus placebo (284±43 mg/h/dl; P<0.05). No significant differences were found in postprandial plasma insulin levels, and no adverse events were observed.
Kondo S, Suzuki A, Kurokawa M, et al. Biomed Rep, 2016. PMID 27882216
2016 / Randomized, double-blind, controlled clinical trial
Sixty patients with Alzheimer's disease were randomized to receive 200 ml/day of control milk or probiotic milk containing Lactobacillus acidophilus, L. casei, Bifidobacterium bifidum, and L. fermentum for 12 weeks. Compared to controls (-5.03% ± 3.00), the probiotic group showed a significant improvement in MMSE scores (+27.90% ± 8.07, P < 0.001). Probiotic intake also led to significant favorable changes in plasma malondialdehyde, serum hs-CRP, HOMA-IR, beta cell function, serum triglycerides, and QUICKI compared with control (all P < 0.01). No considerable effects were observed on fasting plasma glucose, other lipid profiles, or other biomarkers of oxidative stress and inflammation.
Akbari E, Asemi Z, Daneshvar Kakhaki R, et al. Front Aging Neurosci, 2016. PMID 27891089
2016 / Self-controlled crossover trial
A study evaluated the glycaemic index (GI) and postprandial glucose levels after consuming a foxtail millet dosa compared to a rice dosa at breakfast among 105 patients with type 2 diabetes mellitus. Each participant served as their own control. The GI was 59.25 for foxtail millet dosa and 77.96 for rice dosa. Postprandial glucose levels were significantly reduced after consuming the millet-based dosa compared to the rice-based dosa (P<0.001), while no significant reduction was observed in fasting glucose levels.
Narayanan J, Sanjeevi V, Rohini U, et al. Indian J Med Res, 2016. PMID 28361824
2015 / Pooled analysis of randomized controlled trials
A pooled analysis evaluated two 6-month randomized trials involving 450 postmenopausal women with prehypertension or prediabetes. Compared with milk placebo, participants receiving combined soy foods had a smaller decline in serum uric acid, resulting in a net difference of 14.5 micromol/L (95% CI: 1.93-25.6, p = 0.023) or 4.9% (95% CI: 1.3-8.5%, p = 0.023). Soy foods did not raise absolute urate levels.
Liu ZM, Ho CS, Chen YM, et al. Eur J Nutr, 2015. PMID 24659208
2015 / Controlled trial
Thirty patients with type II diabetes 6 weeks post-bypass surgery received counseling on a Modified Portfolio Diet (MPD) including low fat, viscous fibers, soy protein, and almonds, while 7 patients with no diet therapy served as time controls. Consumption of the MPD led to a 19% relative reduction in LDL cholesterol (1.9 ± 0.8 vs 1.6 ± 0.6 mmol/L, p < 0.001) with no change in HDL cholesterol, and homocysteine levels dropped (10.1 ± 2.7 vs 7.9 ± 4 μmol/L, p = 0.006). Flow-mediated dilatation increased from 3.8 ± 3.8% to 6.5 ± 3.6% (p = 0.004) in treated patients while remaining constant in controls (p = 0.6), and endothelial progenitor cell numbers increased significantly (p < 0.02). Time controls showed no significant changes across these measures.
Keith M, Kuliszewski MA, Liao C, et al. Clin Nutr, 2015. PMID 25023926
2015 / Comparative human study
A comparative study evaluated the glycaemic index (GI) and glycaemic load (GL) of various sorghum-based foods compared to wheat- or rice-based controls. The GI of sorghum-based foods including coarse semolina upma (P < 0.05), fine semolina upma (P < 0.01), flakes poha (P < 0.01), and pasta (P < 0.01) was significantly lower than their controls, each qualifying as low GI (<55). All tested sorghum-based foods exhibited significantly lower GL (P < 0.01) than their respective control foods, with the conclusion noting this lower GL applied to all tested sorghum products with the exception of sorghum roti.
Prasad MP, Rao BD, Kalpana K, et al. J Sci Food Agric, 2015. PMID 25092385
2015 / Randomized crossover trial
Thirty-two women participated in randomized crossover protocols comparing lunch at 13:00 to lunch at 16:30. Consuming lunch late decreased pre-meal resting energy expenditure (P=0.048), reduced fasting carbohydrate utilization (P=0.006), and enlarged glucose area under the curve by 46% (P=0.002). Late lunch also altered the post-meal respiratory quotient profile, blunted daily cortisol profiles, and suppressed the postprandial wrist temperature peak (P<0.05).
Bandín C, Scheer FA, Luque AJ, et al. Int J Obes (Lond), 2015. PMID 25311083
2015 / Randomized controlled crossover trial
Thirty-one type 2 diabetes patients were randomized in a crossover trial to an 8-week legume-free Therapeutic Lifestyle Change (TLC) diet and an 8-week legume-based TLC diet (replacing two servings of red meat with legumes 3 days per week), separated by a 4-week washout. Compared with the control diet, the legume-based diet significantly decreased fasting blood glucose (P=0.04), fasting insulin (P=0.04), triglycerides (P=0.04), and LDL cholesterol (P=0.02). Total cholesterol decreased in both diets with no significant difference between them, and BMI, waist circumference, and systolic and diastolic blood pressure did not change significantly between diets.
Hosseinpour-Niazi S, Mirmiran P, Hedayati M, et al. Eur J Clin Nutr, 2015. PMID 25351652
2015 / In vitro study, acute randomized crossover trial, and 24-week RCT
Researchers tested the effects of an inulin-propionate ester using in vitro human colonic cells, an acute randomized controlled crossover trial, and a 24-week randomized controlled study in 60 overweight adults. Acute ingestion of 10 g inulin-propionate ester significantly increased postprandial plasma PYY and GLP-1 and reduced energy intake. Over 24 weeks, supplementation with 10 g/day significantly reduced weight gain, intra-abdominal adipose tissue distribution, and intrahepatocellular lipid content, while preventing the deterioration in insulin sensitivity observed with the inulin control.
Chambers ES, Viardot A, Psichas A, et al. Gut, 2015. PMID 25500202
2015 / Randomized, double-blind, placebo-controlled clinical trial
In a randomized, double-blind, placebo-controlled clinical trial, 41 type 2 diabetic patients received either 2 g/day of ginger powder supplement or lactose placebo for 12 weeks. Compared to baseline and the control group, ginger supplementation significantly reduced levels of fasting blood sugar, hemoglobin A1c, apolipoprotein B, apolipoprotein B/apolipoprotein A-I, and malondialdehyde, while significantly increasing apolipoprotein A-I (p<0.05).
Khandouzi N, Shidfar F, Rajab A, et al. Iran J Pharm Res, 2015. PMID 25561919
2015 / Randomized crossover trial
In a randomized crossover trial, eight adults with impaired glucose tolerance consumed 0.50 mmol vinegar (6% acetic acid) or placebo prior to a mixed meal. Compared with placebo, vinegar ingestion increased forearm muscle blood flow and muscle glucose uptake over 300 minutes (both p < 0.001). Vinegar also significantly decreased arterial plasma insulin and arterial triglycerides (p = 0.005) without altering non-esterified fatty acids or glycerol.
Mitrou P, Petsiou E, Papakonstantinou E, et al. Eur J Clin Nutr, 2015. PMID 25626409
2015 / Randomized controlled trial
In a randomized controlled trial, 240 adults with metabolic syndrome were assigned to a diet focused on increased fiber consumption versus the multicomponent American Heart Association (AHA) dietary guidelines. At 12 months, mean weight change was -2.1 kg (95% CI, -2.9 to -1.3 kg) in the high-fiber group versus -2.7 kg (CI, -3.5 to -2.0 kg) in the AHA group, with a mean between-group difference of 0.6 kg (CI, -0.5 to 1.7 kg). Eight participants developed diabetes (7 in high-fiber, 1 in AHA; P = 0.066), and dropout rates were 9.9% versus 12.6% (P = 0.55). Limitations noted include unknown generalizability, lack of weight maintenance assessment after sessions ended, and lack of power for dietary equivalence.
Ma Y, Olendzki BC, Wang J, et al. Ann Intern Med, 2015. PMID 25686165
2015 / Randomized controlled trial
In a double-blind trial, Iranian adults with type 2 diabetes not using insulin received either 3 g of powdered ginger or a lactose placebo daily for 3 months. Compared with placebo, ginger supplementation significantly decreased fasting serum glucose (-19.41 vs. 1.63 mg/dL, p < 0.001), HbA1c (-0.77% vs. 0.02%, p < 0.001), insulin resistance, and C-reactive protein. It also significantly increased total antioxidant capacity and paraoxonase-1 activity.
Shidfar F, Rajab A, Rahideh T, et al. J Complement Integr Med, 2015. PMID 25719344
2015 / Randomized controlled trial
In a randomized trial of 78 overweight adults, taking Cuminum cyminum L. capsules three times daily for eight weeks reduced body weight (-1.1 ± 1.2 kg) and BMI (-0.4 ± 0.5 kg/m2) to a degree similar to orlistat, both differing from placebo (p = 0.002 and p = 0.003). Cumin also significantly decreased serum insulin (-1.4 ± 4.5 µIU/ml vs 1.3 ± 3.3 for orlistat and 0.3 ± 2.2 for placebo, p = 0.02) and improved insulin sensitivity markers.
Taghizadeh M, Memarzadeh MR, Asemi Z, et al. Ann Nutr Metab, 2015. PMID 25766448
2015 / Interventional study (two sub-studies)
Two studies examined the metabolic adaptations to a 5-day isocaloric high-fat diet (HFD) in 12 healthy, young males. Study 1 found no effect of the HFD on fasting skeletal muscle metabolism or insulin sensitivity. Study 2 revealed that 5 days of an HFD significantly increased fasting serum endotoxin, disrupted postprandial serum endotoxin excursions, and altered skeletal muscle metabolic and transcriptional responses to a high-fat meal challenge, along with altered phosphorylated- to total-p38 protein ratios, all occurring without changes in insulin sensitivity.
Anderson AS, Haynie KR, McMillan RP, et al. Obesity (Silver Spring), 2015. PMID 25820254
2015 / Two 8-day laboratory protocols (controlled trial)
Healthy adults underwent two 8-day laboratory protocols to assess the separate impacts of the circadian system and circadian misalignment on glucose tolerance. Postprandial glucose was 17% higher in the biological evening (8:00 PM) compared with the morning (8:00 AM), which was linked to decreased pancreatic beta-cell function (27% lower early-phase insulin). Circadian misalignment itself increased postprandial glucose by 6%, accompanied by 14% higher late-phase insulin without changes in early-phase insulin, indicating decreased insulin sensitivity.
Morris CJ, Yang JN, Garcia JI, et al. Proc Natl Acad Sci U S A, 2015. PMID 25870289